View clinical trials related to Osteoarthritis Knee Pain.
Filter by:The objectives of this study are to demonstrate the non-inferiority of esflurbiprofen plaster (SFPP) 40 mg applied for 2 weeks to diclofenac gel, the comparator, in terms of efficacy in patients with knee osteoarthritis (OA) and to examine the safety of SFPP.
The study will test the hypothesis that, in patients with knee pain due to osteoarthritis (OA) who are taking nonsteroidal anti-inflammatory drugs (NSAIDs) but still have significant knee pain, duloxetine 60 to 120 milligrams (mg) daily for 10 weeks will provide additional reduction in pain.
The primary purpose of this study is to determine if duloxetine 60 mg once daily (QD) reduces pain severity in patients with osteoarthritis (OA) knee pain compared with placebo.
To gather data on whether a new drug for osteoarthritis knee pain will be safe and have an effect on pain levels.
The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.
The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.